AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
- Posted on August 2, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
